Back to search
FDAFDA · Food and drugs·Recall number Z-0556-2016

Granada Biphasic Broth The product is a selective medium for the screening and identification of Streptococcus agalactiae in pregnant women using clinical specimens.

Published January 6, 2016 · Recall initiated: November 23, 2015

Summary

FDA records medical device Class II recall Z-0556-2016, published January 6, 2016 and initiated November 23, 2015. Recalling firm: Biomerieux Inc; Status: Terminated; Reported quantity: 24 cartons; Lot: REF 42722 - Lot Numbers 896, 897 & 899. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

FDA has determined that the product requires 510(k) clearance to continue marketing/distribution in the United States.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Biomerieux Inc
Distributor
US Distribution to states of: CA, GA, IN, MA, MN, MO, NY, OH and PA.
Lot
REF 42722 - Lot Numbers 896, 897 & 899
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Granada Biphasic Broth The product is a selective medium for the screening and identification of Streptococcus agalactiae in pregnant women using clinical specimens. recalled?

Yes. FDA published recall Z-0556-2016 on January 6, 2016. Reported hazard: FDA has determined that the product requires 510(k) clearance to continue marketing/distribution in the United States.

What should I do if I have this product?

Voluntary: Firm initiated · Letter